Thailand Aesthetic Medicine Market Size, Trends, Share, Growth | Report 2022-2030
The Thailand aesthetic medicine market was surpassed at USD 1.52 billion in 2021 and is expected to hit around USD 3.54 billion by 2030, growing at a CAGR of 9.85% from 2022 to 2030.
Report Highlights
The market is majorly driven by the increasing adoption of minimally invasive and non-invasive procedures coupled with growth in the population susceptible to signs of aging. Moreover, an increase in the incidence of road accidents is fuelling the demand for reconstructive surgeries, which is fuelling the growth of the market. According to the International Society of Aesthetic Plastic Surgery (ISAPS), among Asian countries, Thailand is among the top ten countries with the highest volume of invasive as well as non-invasive procedures. Cities, such as Bangkok and Phuket, are major cosmetic surgery hubs in the country, which have clusters of major aesthetic surgery hospitals and clinics.
According to a survey by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, around 154,547 aesthetic procedures were performed in the country. Moreover, Thailand is a tourism-dependent economy where medical tourism is flourishing due to low treatment costs and high-quality post-treatment services. According to the Journal of Community Development Research, Thailand’s medical tourism industry expanded with a 10% revenue growth in 2019 from 2018. These factors might boost market growth. The advent of the COVID-19 pandemic has resulted in the cessation of medical tourism in Thailand during the first half of 2020. However, the market recovered significantly by 2021 and the procedural volume of aesthetic procedures both invasive and non-invasive was higher in 2020 as compared to 2019 indicating the rising demand for aesthetic treatments in the country.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 1.52 billion |
| Revenue Forecast by 2030 | USD 3.54 billion |
| Growth rate from 2022 to 2030 | CAGR of 9.85% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Procedure type, end-use |
| Companies Covered | Dermaster Co., Ltd.; BSL Clinic; Thai Medical Vacation; Bumrungrad International Hospital; Dr. Orawan Holistic Dermatology & Anti-Aging Institute; Nirunda International Aesthetic Clinic |
Procedure Type Insights
The invasive procedure segment held a maximum share of around 74.07% of the overall market revenue in 2021. According to a survey by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2021, around 102,407 invasive aesthetic procedures were performed in the country, with eyelid surgery, rhinoplasty, and breast augmentation being the most frequently performed procedures. This is because invasive procedures are cheaper in the country as compared to other Western countries, as its currency is weaker than that of European and North American countries, and patients can save around 20-65% of their cost.
The Invasive procedure segment is further segmented into Breast augmentation, liposuction, nose reshaping, eyelid surgery, tummy tuck, and others. The eyelid surgery segment held a significant market share in 2021. Since a majority of the Thai population does not have creased eyelids, they opt for eyelid surgeries to gain a defined eye shape and remove sagging. Non-invasive procedures are expected to witness the highest growth during the forecast period owing to the fact that they offer pain-free cosmetic treatments with zero downtime and a reduced recovery period. This is anticipated to fuel the demand for these treatments. The most popular treatments were skin tightening, Botox injections, and non-invasive fat reduction.
End-use Insights
The clinics & aesthetic centers segment held the highest market share of more than 69.6% in 2021 and is also anticipated to grow lucratively during the forecast period. Clinics are frequently visited by patients for aesthetic procedures, such as skin rejuvenation, body contouring & reshaping, wrinkle reduction, and scar treatment. Dermatology and beauty clinics are increasingly adopting technologically advanced aesthetic systems that can cater to a wide range of skin conditions and this has resulted in high patient footfall. The Health Service Support Department’s Sanatorium and Art of Healing Bureau is the regulatory body that oversees private clinics and private hospitals in the country.
The country has 1,458 clinics that provide aesthetic services and represent 13% of all medical clinics in Thailand. However, the clinic segment is not efficiently regulated, and many complaints have been filed to the Office of the Consumer Protection Board related to aesthetic surgery over the years. This might hamper the market growth. Thailand is becoming a major tourist destination and 60% of all the foreigners visiting the country are there for cosmetic surgery procedures. The majority of the hospitals in the country are certified and accredited by Joint Commission International (JCI). This international organization promotes strict adherence to quality care in 90 countries globally. Such accreditations boost reliability and trust among patients seeking treatment in the country.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Thailand Aesthetic Medicine Market
5.1. COVID-19 Landscape: Thailand Aesthetic Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Thailand Aesthetic Medicine Market, By Procedure Type
8.1. Thailand Aesthetic Medicine Market, by Procedure Type, 2022-2030
8.1.1. Invasive Procedures
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Non-invasive procedures
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Thailand Aesthetic Medicine Market, By End-use
9.1. Thailand Aesthetic Medicine Market, by End-use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Clinics & Aesthetic centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Thailand Aesthetic Medicine Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.1.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.5.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Procedure Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 11. Company Profiles
11.1. Dermaster Co., Ltd.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. BSL Clinic
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Thai Medical Vacation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bumrungrad International Hospital
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Dr. Orawan Holistic Dermatology & Anti-Aging Institute
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Nirunda International Aesthetic Clinic
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers